Literature DB >> 23922175

Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression.

Chun-Te Wu1, Wen-Ching Wang, Miao-Fen Chen, Hou-Yu Su, Wei-Yu Chen, Chih-Hsiung Wu, Yu-Jia Chang, Hui-Hsiung Liu.   

Abstract

Glucose-regulated protein 78 (GRP78) plays an essential role in embryonic development and in the progression and therapeutic resistance of many cancers. However, little is known about the function of GRP78 in hormone-independent prostate cancer. Here, we found that the expression levels of GRP78 were higher in PC-3 cells than in DU-145 cells. When the expression of GRP78 was silenced using a GRP78-specific small interfering RNA in PC-3 cells, the growth rate and adhesive ability were reduced. Cell migration was dramatically decreased in GRP78-depleted cells. Dissection of the involved signal pathways revealed that maspin expression was upregulated after silencing GRP78 expression. The upregulation of maspin and downregulation of COX-2 may cause the decrease in cell proliferation and migration observed after silencing GRP78 expression. Silencing GRP78 expression may suppress the proliferation, adhesion, and migration of prostate cancer cells via maspin and COX-2 regulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23922175     DOI: 10.1007/s13277-013-1024-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  53 in total

1.  The ER function BiP is a master regulator of ER function.

Authors:  Linda M Hendershot
Journal:  Mt Sinai J Med       Date:  2004-10

2.  Histamine regulates cyclooxygenase 2 gene activation through Orai1-mediated NFκB activation in lung cancer cells.

Authors:  Wan-Chen Huang; Chee-Yin Chai; Wei-Chiao Chen; Ming-Feng Hou; Yu-Shiuan Wang; Yi-Ching Chiu; Shiang-Ru Lu; Wen-Chang Chang; Suh-Hang Hank Juo; Jaw-Yuan Wang; Wei-Chiao Chang
Journal:  Cell Calcium       Date:  2011-05-24       Impact factor: 6.817

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  G-helix of maspin mediates effects on cell migration and adhesion.

Authors:  Lorna Ravenhill; Laura Wagstaff; Dylan R Edwards; Vincent Ellis; Rosemary Bass
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

5.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.

Authors:  Masahiro Shuda; Nobuo Kondoh; Nobuo Imazeki; Kenji Tanaka; Tetsuya Okada; Kazutoshi Mori; Akiyuki Hada; Masaaki Arai; Toru Wakatsuki; Osamu Matsubara; Naoki Yamamoto; Mikio Yamamoto
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

6.  COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.

Authors:  Fengjuan Lin; Jianmin Luo; Wen Gao; Jiong Wu; Zhimin Shao; Ziliang Wang; Jiao Meng; Zhouluo Ou; Gong Yang
Journal:  Tumour Biol       Date:  2013-06-15

7.  Maspin reduces prostate cancer metastasis to bone.

Authors:  Devon C Hall; Teresa L Johnson-Pais; Barry Grubbs; Rosie Bernal; Robin J Leach; Susan S Padalecki
Journal:  Urol Oncol       Date:  2008-01-15       Impact factor: 3.498

Review 8.  Hypoxia-regulated target genes implicated in tumor metastasis.

Authors:  Ya-Ping Tsai; Kou-Juey Wu
Journal:  J Biomed Sci       Date:  2012-12-14       Impact factor: 8.410

9.  Role of maspin in cancer.

Authors:  Rossana Berardi; Francesca Morgese; Azzurra Onofri; Paola Mazzanti; Mirco Pistelli; Zelmira Ballatore; Agnese Savini; Mariagrazia De Lisa; Miriam Caramanti; Silvia Rinaldi; Silvia Pagliaretta; Matteo Santoni; Chiara Pierantoni; Stefano Cascinu
Journal:  Clin Transl Med       Date:  2013-03-07

10.  Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization.

Authors:  Yuh-Cherng Guo; Che-Mai Chang; Wen-Li Hsu; Siou-Jin Chiu; Yao-Ting Tsai; Yii-Her Chou; Ming-Feng Hou; Jaw-Yan Wang; Mei-Hsien Lee; Ke-Li Tsai; Wei-Chiao Chang
Journal:  Molecules       Date:  2013-06-04       Impact factor: 4.411

View more
  12 in total

1.  Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

Authors:  Li-Jen Kuo; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Chun-Te Wu; Feng-Yen Lin; Yu-Jia Chang; Ming-Te Huang
Journal:  Tumour Biol       Date:  2015-02-11

2.  Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers.

Authors:  Chun-Te Wu; Yu-Jia Chang; Miao-Fen Chen; Jun-Jen Liu; Po-Li Wei; Weu Wang; Hui-Hsiung Liu
Journal:  Tumour Biol       Date:  2014-03-15

3.  GRP78 mediates the therapeutic efficacy of curcumin on colon cancer.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Wei-Yu Chen; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-10-04

4.  Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2015-01-25

5.  GRP78 promotes the invasion of pancreatic cancer cells by FAK and JNK.

Authors:  X P Yuan; Ming Dong; Xin Li; J P Zhou
Journal:  Mol Cell Biochem       Date:  2014-09-14       Impact factor: 3.396

Review 6.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

7.  GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy.

Authors:  Bing Jiang; Ruofei Zhang; Jianlin Zhang; Yaxin Hou; Xuehui Chen; Meng Zhou; Xiuyun Tian; Chunyi Hao; Kelong Fan; Xiyun Yan
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

8.  Glucose- regulated protein 78 (GRP78) in renal cell carcinoma: A novel biomarker for predicting tumor behavior.

Authors:  Manoj Kumar; Harshit Garg; Nidhi Gupta; Alpana Sharma; Seema Kaushal; Rajeev Kumar; Amit Kumar Dinda
Journal:  Heliyon       Date:  2021-06-15

9.  Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer.

Authors:  Zheyu Niu; Mengyi Wang; Li Zhou; Lutian Yao; Quan Liao; Yupei Zhao
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

10.  Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78.

Authors:  Yue Zhang; Wen-Peng Xie; Yong-Kui Zhang; Yi-Qiang Chen; Dong-Li Wang; Gang Li; Dong-Hui Guan
Journal:  Onco Targets Ther       Date:  2018-01-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.